Clinical Trial Update: Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136 [Phase 3]

View source ↗

Summary

Phase 3 study ANRS136 compared darunavir boosted with ritonavir to HART with two NRTIs in HIV-1 infected patients; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (darunavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 3 | Status: COMPLETED